Benjamin Johan, Maillard Laure, Morelec Isabelle, Got Philippe, Borson-Chazot Françoise, Lifante Jean-Christophe
Service de Chirurgie Endocrinienne, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.
Service de Médecine Nucléaire, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.
Cancers (Basel). 2022 Apr 17;14(8):2029. doi: 10.3390/cancers14082029.
This large, retrospective, single-centre study evaluated the diagnostic performance of F-choline positron emission tomography/contrast-enhanced computed tomography (PET/ceCT) in preoperative parathyroid adenoma detection in primary hyperparathyroidism cases after negative/inconclusive ultrasound or other imaging findings. We included patients who underwent surgery and F-choline PET/ceCT for inconclusive imaging results between 2015 and 2020. We compared the F-choline PET/ceCT results with surgical and histopathological findings and identified the variables influencing the correlation between F-choline PET/ceCT and surgical findings. Of 215 enrolled patients, 269 glands (mean lesion size, 10.9 ± 8.0 mm) were analysed. There were 165 unilocular and 50 multilocular lesions; the mean preoperative calcium level was 2.18 ± 0.19 mmol/L. Among 860 estimated lesions, 219 were classified as true positive, 21 as false positive, and 28 as false negative. The per-lesion sensitivity was 88.66%; specificity, 96.57%; positive predictive value, 91.40%; and negative predictive value, 95.39%. The detection and cure rates were 82.0% and 95.0%, respectively. On univariate and multivariate analyses, the maximum standardised uptake value (SUVmax), lesion size, and unilocularity correlated with the pathologic findings of hyperfunctioning glands. F-choline PET/ceCT presents favourable diagnostic performance as a second-line imaging method, with SUVmax, lesion size, and unilocularity predicting a high correlation between the F-choline PET/ceCT and surgical findings.
这项大型回顾性单中心研究评估了F-胆碱正电子发射断层扫描/对比增强计算机断层扫描(PET/ceCT)在原发性甲状旁腺功能亢进症患者术前甲状旁腺腺瘤检测中的诊断性能,这些患者的超声或其他影像学检查结果为阴性或不确定。我们纳入了2015年至2020年间因影像学检查结果不确定而接受手术和F-胆碱PET/ceCT检查的患者。我们将F-胆碱PET/ceCT结果与手术和组织病理学结果进行了比较,并确定了影响F-胆碱PET/ceCT与手术结果相关性的变量。在215名入组患者中,分析了269个腺体(平均病变大小为10.9±8.0mm)。有165个单房病变和50个多房病变;术前平均钙水平为2.18±0.19mmol/L。在860个估计病变中,219个被分类为真阳性,21个为假阳性,28个为假阴性。每个病变的敏感性为88.66%;特异性为96.57%;阳性预测值为91.40%;阴性预测值为95.39%。检测率和治愈率分别为82.0%和95.0%。单因素和多因素分析显示,最大标准化摄取值(SUVmax)、病变大小和单房性与功能亢进腺体的病理结果相关。F-胆碱PET/ceCT作为二线成像方法具有良好的诊断性能,SUVmax、病变大小和单房性可预测F-胆碱PET/ceCT与手术结果之间的高度相关性。